pubmed-article:9836456 | pubmed:abstractText | Continuing our studies connected with the design of antipsychotic and anxiolytic agents with a reduced propensity toward extrapyramidal side-effects, the synthesis of new compounds related to 3,7-dimethyltricyclo [6.2.2.0(1,6)] dodecen-6-yl-9,10,11,12-tetracarboxydiimide was performed. The first result of the pharmacological screening test of two of synthesized compounds displayed their low affinity for the serotonin receptor site. | lld:pubmed |